Oaktree Acquisition Corp. II
Venture Capital
SPAC sponsored by Oaktree Capital Management that raised $250M in a Sept 2020 IPO and merged with Alvotech, an Icelandic biosimilars company, in a $2.28B deal announced Dec 2021.
Los Angeles, United States · 3+ investments
Late Stage
Public
Healthcare
Industrials
Life Sciences
- Headquarters
- Los Angeles, United States
- Founded
- 2020
- Website
- oaktreecapital.com
- Total Investments
- 3
- Last Investment
- Dec 2021
- Geographic Focus
- Global, United States
Investment Thesis
Blank-check SPAC formed to acquire a high-quality growth business; completed merger with Alvotech (biosimilars) in 2022.
Oaktree Acquisition Corp. II is a Venture Capital firm based in Los Angeles, United States. It has made 3 investments in Healthcare and Industrials.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.